Return on equity reveals how much profit a company earned in comparison to the total amount of shareholder equity found on the balance sheet. The DuPont formula is a common way to break down ROE into three important components. Essentially, ROE will equal the net margin multiplied by asset turnover multiplied by financial leverage.
Widely used by investors, the ROE ratio shows the return being generated for every pound of equity on the balance sheet. It should be thought of as the 'internal return' that the company generates, and should not be mistaken with the market returns that shareholders may attain.
It varies by industry but ROEs of 15% or over are usually considered desirable. High ROE numbers sustained over the long term may indicate a company has a 'sustainable competitive advantage'. Such companies tend to sell at higher valuation multiples.
The impact of leverage is one of the disadvantages of focusing on ROEs as it can skew ROE upwards - an alternative is to look at Return on Capital Employed.
| Ticker | Name | ROE % PTTM | StockRank™ |
|---|---|---|---|
| NSI:IRBINVIT | IRB InvIT Fund | 29052837.5 | 85 |
| OTC:NUMD | Nu-Med Plus Inc | 22646.41 | 45 |
| AMS:PNL | PostNL NV | 17900 | 47 |
| NYQ:BPT | BP Prudhoe Bay Royalty Trust | 10567.76 | 56 |
| NYQ:NRT | North European Oil Royalty Trust | 7202.45 | 71 |
Let’s get you setup so you get the most out of our service
Brilliant - You've created a folio! Now let's add some stocks to it.
